USPTO serial 90780437
BCRX
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- VELTEN, MALLORY KATE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BCRX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Erica L. Han
Erica L. Han Ropes & Gray LLPPrudential Tower, 800 Boylston StreetBoston, MA 02199-3600United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Pharmaceutical research services; pharmaceutical drug development services; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceutical preparations and medicines for the treatment of infectious, viral, inflammatory, immunological, autoimmune, and cardiovascular diseases and disorders; development of pharmaceutical preparations and medicines for the treatment of cancer, namely, cancers of the immune system, namely, T-cell and B-cell leukemias and lymphomas; development of pharmaceutical preparations and medicines for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; development of pharmaceutical preparations and medicines for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases, and inflammatory skin diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 28, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 28, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 11, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 10, 2025 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Mar 10, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 22, 2024 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 22, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 24, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 24, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 24, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 21, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 17, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 17, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 17, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 22, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 20, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 20, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 20, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 8, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 6, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 6, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 6, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 21, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 26, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 26, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 6, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 23, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 14, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 14, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 14, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 14, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 8, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 29, 2021 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Dec 29, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 27, 2021 | ALIE | ASSIGNED TO LIE | — |
| Dec 22, 2021 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Dec 15, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 15, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 15, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 3, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 21, 2021 | NWAP | NEW APPLICATION ENTERED | — |